Literature DB >> 28537543

Molecular epidemiology of hepatitis B virus infection in Tanzania.

Joseph C Forbi1, Michael Dillon2, Michael A Purdy1, Bakary S Drammeh3, Alexandra Tejada-Strop1, Daniel McGovern1, Guo-Liang Xia1, Yulin Lin1, Lilia M Ganova-Raeva1, David S Campo1, Hong Thai1, Gilberto Vaughan1, Dunstan Haule4, Regina P Kutaga5, Sridhar V Basavaraju3, Saleem Kamili1, Yury E Khudyakov1.   

Abstract

Despite the significant public health problems associated with hepatitis B virus (HBV) in sub-Saharan Africa, many countries in this region do not have systematic HBV surveillance or genetic information on HBV circulating locally. Here, we report on the genetic characterization of 772 HBV strains from Tanzania. Phylogenetic analysis of the S-gene sequences showed prevalence of HBV genotype A (HBV/A, n=671, 86.9 %), followed by genotypes D (HBV/D, n=95, 12.3 %) and E (HBV/E, n=6, 0.8 %). All HBV/A sequences were further classified into subtype A1, while the HBV/D sequences were assigned to a new cluster. Among the Tanzanian sequences, 84 % of HBV/A1 and 94 % of HBV/D were unique. The Tanzanian and global HBV/A1 sequences were compared and were completely intermixed in the phylogenetic tree, with the Tanzanian sequences frequently generating long terminal branches, indicating a long history of HBV/A1 infections in the country. The time to the most recent common ancestor was estimated to be 188 years ago [95 % highest posterior density (HPD): 132 to 265 years] for HBV/A1 and 127 years ago (95 % HPD: 79 to 192 years) for HBV/D. The Bayesian skyline plot showed that the number of transmissions 'exploded' exponentially between 1960-1970 for HBV/A1 and 1970-1990 for HBV/D, with the effective population of HBV/A1 having expanded twice as much as that of HBV/D. The data suggest that Tanzania is at least a part of the geographic origin of the HBV/A1 subtype. A recent increase in the transmission rate and significant HBV genetic diversity should be taken into consideration when devising public health interventions to control HBV infections in Tanzania.

Entities:  

Keywords:  Tanzania; evolution; hepatitis B virus; molecular epidemiology

Year:  2017        PMID: 28537543     DOI: 10.1099/jgv.0.000776

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

Review 1.  Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Authors:  Mindie H Nguyen; Grace Wong; Edward Gane; Jia-Horng Kao; Geoffrey Dusheiko
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

Review 2.  Hepatitis B Virus Infection in Tanzania: Current Status and Challenges.

Authors:  Semvua B Kilonzo; Daniel W Gunda; Bonaventura C T Mpondo; Fatma A Bakshi; Hyasinta Jaka
Journal:  J Trop Med       Date:  2018-01-30

3.  Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.

Authors:  Mary C Kuhns; Anne L McNamara; Vera Holzmayer; Gavin A Cloherty
Journal:  Virol J       Date:  2019-04-03       Impact factor: 4.099

4.  Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study.

Authors:  Karin Geffert; Tongai G Maponga; Shimba Henerico; Wolfgang Preiser; Stella Mongella; August Stich; Samuel Kalluvya; Andreas Mueller; Christa Kasang
Journal:  BMC Infect Dis       Date:  2020-06-05       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.